AI-Assisted Identification and Quantification of Pharmaceutical Impurities using HPLC Chromatographic Data

Abstract

Pharmaceutical impurities present in active pharmaceutical ingredients (APIs) and finished drug products can have profound impacts on drug safety, efficacy, and stability. Regulatory authorities such as the International Council for Harmonisation (ICH), U.S. Food and Drug Administration (FDA), and European Medicines Agency (EMA) require stringent impurity identification and quantification to ensure drug quality and patient safety. High-Performance Liquid Chromatography (HPLC) remains the most common analytical method for impurity profiling, thanks to its high sensitivity, precision, and ability to separate complex mixtures. However, traditional HPLC data interpretation relies heavily on manual analysis, making it time-consuming, operator-dependent, and prone to human error. Artificial Intelligence (AI) and Machine Learning (ML) have emerged as transformative tools for automating chromatographic data analysis, enabling rapid and accurate impurity detection, identification, and quantification. AI algorithms can efficiently process large chromatographic datasets, identify subtle peak patterns, correct baseline drifts, and predict retention behaviours under various chromatographic conditions. This comprehensive article explores the integration of AI approaches into HPLC impurity profiling, covering theoretical foundations, data preprocessing, peak recognition, automated quantification, and future implications for pharmaceutical quality control and regulatory compliance.